DRW Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,331
Closed -$373K – 1012
2026
Q1
$373K Sell
6,331
-1,376
-18% -$80.2K 0.01% 770
2025
Q4
$416K Buy
+7,707
New +$371K 0.01% 524
2025
Q1
– Sell
-5,056
Closed -$285K – 602
2024
Q4
$285K Buy
+5,056
New +$282K 0.01% 439
2024
Q2
– Sell
-14,585
Closed -$791K – 536
2024
Q1
$791K Buy
14,585
+1,856
+15% +$94.5K 0.02% 197
2023
Q4
$653K Buy
12,729
+8,740
+219% +$459K 0.01% 171
2023
Q3
$232K Sell
3,989
-912
-19% -$55.9K ﹤0.01% 295
2023
Q2
$313K Sell
4,901
-6,281
-56% -$421K 0.01% 250
2023
Q1
$775K Buy
+11,182
New +$789K 0.01% 166
2022
Q4
– Sell
-6,983
Closed -$496K – 269
2022
Q3
$496K Buy
6,983
+4,249
+155% +$308K 0.01% 148
2022
Q2
$211K Sell
2,734
-9,020
-77% -$687K 0.01% 228
2022
Q1
$858K Buy
11,754
+5,983
+104% +$402K 0.02% 137
2021
Q4
$360K Buy
+5,771
New +$339K 0.01% 168
2021
Q3
– Sell
-6,929
Closed -$463K – 261
2021
Q2
$463K Buy
+6,929
New +$452K 0.01% 185
2020
Q2
– Sell
-44,053
Closed -$2.45M – 181
2020
Q1
$2.45M Buy
+44,053
New +$2.69M 0.09% 57
2018
Q1
– Sell
-22,944
Closed -$1.41M – 214
2017
Q4
$1.41M Buy
+22,944
New +$1.44M 0.15% 86
2013
Q3
– Sell
-10,000
Closed -$447K – 170
2013
Q2
$447K Buy
+10,000
New +$434K 0.02% 144

Other funds holding BMY

DRW Securities's BMY Position: Q2 2026 in Review

DRW Securities sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 6,331 shares — an estimated $373K sold.

DRW Securities first reported a position in BMY in Q2 2013 and held it in 16 quarters. The position peaked at $2.45M in Q1 2020. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • DRW Securities reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 6,331 Bristol-Myers Squibb shares in Q2 2026, an estimated $373K.
  • DRW Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 16 quarters.
  • DRW Securities's Bristol-Myers Squibb position peaked at $2.45M in Q1 2020.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.